These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24501411)

  • 1. Enhancers are major targets for murine leukemia virus vector integration.
    De Ravin SS; Su L; Theobald N; Choi U; Macpherson JL; Poidinger M; Symonds G; Pond SM; Ferris AL; Hughes SH; Malech HL; Wu X
    J Virol; 2014 Apr; 88(8):4504-13. PubMed ID: 24501411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
    Moiani A; Miccio A; Rizzi E; Severgnini M; Pellin D; Suerth JD; Baum C; De Bellis G; Mavilio F
    PLoS One; 2013; 8(1):e55721. PubMed ID: 23383272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BET-Independent Murine Leukemia Virus Integration Is Retargeted
    Nombela I; Michiels M; Van Looveren D; Marcelis L; El Ashkar S; Van Belle S; Bruggemans A; Tousseyn T; Schwaller J; Christ F; Gijsbers R; De Rijck J; Debyser Z
    Microbiol Spectr; 2022 Aug; 10(4):e0147822. PubMed ID: 35852337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors.
    Sokol M; Wabl M; Ruiz IR; Pedersen FS
    Retrovirology; 2014 May; 11():36. PubMed ID: 24886479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells.
    De Palma M; Montini E; Santoni de Sio FR; Benedicenti F; Gentile A; Medico E; Naldini L
    Blood; 2005 Mar; 105(6):2307-15. PubMed ID: 15542582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
    Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
    Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
    Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
    Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin states shape insertion profiles of the piggyBac, Tol2 and Sleeping Beauty transposons and murine leukemia virus.
    Yoshida J; Akagi K; Misawa R; Kokubu C; Takeda J; Horie K
    Sci Rep; 2017 Mar; 7():43613. PubMed ID: 28252665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription start regions in the human genome are favored targets for MLV integration.
    Wu X; Li Y; Crise B; Burgess SM
    Science; 2003 Jun; 300(5626):1749-51. PubMed ID: 12805549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.
    Hlavaty J; Stracke A; Klein D; Salmons B; Günzburg WH; Renner M
    J Virol; 2004 Feb; 78(3):1384-92. PubMed ID: 14722293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model.
    Loyola L; Achuthan V; Gilroy K; Borland G; Kilbey A; Mackay N; Bell M; Hay J; Aiyer S; Fingerman D; Villanueva RA; Cameron E; Kozak CA; Engelman AN; Neil J; Roth MJ
    PLoS Pathog; 2019 Dec; 15(12):e1008154. PubMed ID: 31815961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.
    De Rijck J; de Kogel C; Demeulemeester J; Vets S; El Ashkar S; Malani N; Bushman FD; Landuyt B; Husson SJ; Busschots K; Gijsbers R; Debyser Z
    Cell Rep; 2013 Nov; 5(4):886-94. PubMed ID: 24183673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors.
    Hu J; Renaud G; Gomes TJ; Ferris A; Hendrie PC; Donahue RE; Hughes SH; Wolfsberg TG; Russell DW; Dunbar CE
    Mol Ther; 2008 Sep; 16(9):1617-23. PubMed ID: 18578011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.
    Tsukahara T; Agawa H; Matsumoto S; Matsuda M; Ueno S; Yamashita Y; Yamada K; Tanaka N; Kojima K; Takeshita T
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1099-107. PubMed ID: 16713998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements.
    El Ashkar S; De Rijck J; Demeulemeester J; Vets S; Madlala P; Cermakova K; Debyser Z; Gijsbers R
    Mol Ther Nucleic Acids; 2014 Jul; 3(7):e179. PubMed ID: 25072693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.
    Bester AC; Schwartz M; Schmidt M; Garrigue A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Ben-Porat N; Von Kalle C; Fischer A; Kerem B
    Gene Ther; 2006 Jul; 13(13):1057-9. PubMed ID: 16511518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proviruses with Long-Term Stable Expression Accumulate in Transcriptionally Active Chromatin Close to the Gene Regulatory Elements: Comparison of ASLV-, HIV- and MLV-Derived Vectors.
    Miklík D; Šenigl F; Hejnar J
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29517993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
    Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors.
    Cattoglio C; Pellin D; Rizzi E; Maruggi G; Corti G; Miselli F; Sartori D; Guffanti A; Di Serio C; Ambrosi A; De Bellis G; Mavilio F
    Blood; 2010 Dec; 116(25):5507-17. PubMed ID: 20864581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BET proteins promote efficient murine leukemia virus integration at transcription start sites.
    Sharma A; Larue RC; Plumb MR; Malani N; Male F; Slaughter A; Kessl JJ; Shkriabai N; Coward E; Aiyer SS; Green PL; Wu L; Roth MJ; Bushman FD; Kvaratskhelia M
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12036-41. PubMed ID: 23818621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.